FIG. 4.
Countin enhances cAMP-stimulated GFP-CRAC binding to membranes. (A) Treatment of cells with anti-countin antibodies inhibits CRAC translocation to the membrane. CRAC-GFP/crac− cells were treated as described in the legend of Fig. 3A, and Western blots were stained with anti-GFP antibodies. The graph shows data normalized as described for Fig. 3 from three separate experiments. The difference at 5 s was significant (P < 0.05; t test). (B) A 1-min treatment of cells with recombinant countin enhances cAMP-stimulated CRAC-GFP binding to membranes. CRAC-GFP/crac− cells were treated as described in the legend of Fig. 3C, and Western blots of the membranes were stained with anti-GFP antibodies. The graph shows data normalized as described for panel A from three separate experiments. The difference at 5 s was significant (P < 0.05; t test).
